Загрузка...
5PSQ-084 Safety and effectiveness of switching to infliximab biosimilar in digestive and rheumatological pathology
BACKGROUND: The introduction of biosimilar drugs into clinical practice allows us to maintain the effectiveness and safety of treatments, taking greater advantage of health resources PURPOSE: The objective of the study was to evaluate the safety and effectiviness of infliximab biosimilar (IFXb) in p...
Сохранить в:
| Опубликовано в: : | Eur J Hosp Pharm |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Group
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535443/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.438 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|